| scholarly article | Q13442814 |
| P2093 | author name string | Peter S Heeger | |
| Deirdre Sawinski | |||
| Donald E Hricik | |||
| Joshua J Augustine | |||
| Lara Danziger-Isakov | |||
| Emilio D Poggio | |||
| Marie Budev | |||
| Robert Fairchild | |||
| Leonid Cherkassky | |||
| Hanni Siegel | |||
| Kristen Kramer | |||
| Mary McManamon | |||
| P2860 | cites work | Influenza-associated hospitalizations in the United States | Q29619463 |
| Mechanisms underlying blockade of allograft acceptance by TLR ligands | Q33732481 | ||
| Heterologous immunity provides a potent barrier to transplantation tolerance | Q35095576 | ||
| T-Cell Allorecognition and Transplant Rejection: A Summary and Update | Q35129543 | ||
| Heterologous immunity: an overlooked barrier to tolerance | Q35583521 | ||
| Heterologous immunity and homeostatic proliferation as barriers to tolerance | Q35876748 | ||
| Frontiers in nephrology: T cell memory as a barrier to transplant tolerance. | Q36883353 | ||
| Memory T cells in allograft rejection | Q36916267 | ||
| Update on immunizations in solid organ transplant recipients: what clinicians need to know | Q37037796 | ||
| The multiple facets of toll-like receptors in transplantation biology | Q37214491 | ||
| Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation | Q40523980 | ||
| Influenza virus infection in adult solid organ transplant recipients | Q40579386 | ||
| Association of renal allograft rejection with virus infections | Q40906023 | ||
| Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. | Q40936737 | ||
| The humoral immune response to influenza vaccination in lung transplant patients | Q43877540 | ||
| Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients | Q44482864 | ||
| Cardiac-allograft vasculopathy | Q44566067 | ||
| Cell-mediated immune response to influenza vaccination in lung transplant recipients | Q45101043 | ||
| Influenza vaccine does not cause rejection after cardiac transplantation | Q46277264 | ||
| Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients | Q46442971 | ||
| Influenza vaccination is efficacious and safe in renal transplant recipients | Q46830965 | ||
| Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy | Q47302070 | ||
| Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? | Q47428977 | ||
| Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. | Q50590166 | ||
| Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. | Q51826320 | ||
| Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. | Q51975758 | ||
| Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. | Q52009929 | ||
| Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. | Q52016711 | ||
| Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. | Q53563172 | ||
| Influenza vaccination on renal transplant patients is safe and serologically effective. | Q54441113 | ||
| Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study | Q57000068 | ||
| Viral Infection and Renal Transplant Rejection | Q57116330 | ||
| Viral triggers of cardiac-allograft dysfunction | Q64379833 | ||
| Virus Infections and Acute Renal Transplant Rejection | Q66844115 | ||
| T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection | Q74817270 | ||
| TLR engagement prevents transplantation tolerance | Q80256970 | ||
| Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? | Q80369913 | ||
| Analysis of immune markers in human cardiac allograft recipients and association with coronary artery vasculopathy | Q81321507 | ||
| Improving clinical practice: should we give influenza vaccinations to heart transplant patients? | Q82684895 | ||
| Guidelines for vaccination of solid organ transplant candidates and recipients | Q95823650 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 838-844 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Effects of influenza immunization on humoral and cellular alloreactivity in humans | |
| P478 | volume | 89 |
| Q34390072 | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host |
| Q37769912 | Alloreactivity from human viral specific memory T-cells |
| Q30356208 | Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients. |
| Q30420230 | Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients |
| Q38225998 | Changing face of vaccination in immunocompromised hosts |
| Q41147045 | Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q30403833 | De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients |
| Q34446000 | Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture |
| Q30353821 | Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients. |
| Q40380028 | Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory |
| Q30383985 | Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series |
| Q30406140 | Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients |
| Q35580676 | Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker |
| Q30399281 | Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients |
| Q30403135 | Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients. |
| Q38235003 | Immunization after kidney transplantation-what is necessary and what is safe? |
| Q30406926 | Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients |
| Q36832305 | Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients |
| Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
| Q30407134 | Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study |
| Q42220410 | Influenza vaccination and humoral alloimmunity in solid organ transplant recipients |
| Q28740919 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective |
| Q37940524 | Influenza vaccination in the organ transplant recipient: review and summary recommendations. |
| Q38262909 | Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation |
| Q33424887 | Pathogenicity of Bovine Neonatal Pancytopenia-associated vaccine-induced alloantibodies correlates with Major Histocompatibility Complex class I expression |
| Q57182370 | Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence |
| Q30421507 | Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. |
| Q42176587 | Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients |
| Q37965366 | TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. |
| Q38672985 | The impact of vaccination on RBC alloimmunization in a murine model. |
| Q38734701 | The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia. |
Search more.